The Europe Intravenous Immunoglobulin Market would witness market growth of 6.4% CAGR during the forecast period (2022-2028).
Intravenous infusion is the process of administering IVIg by a drip into a vein. If an individual is merely taking it to boost the immunoglobulin levels after other therapies, it's sometimes given as a muscle injection. Each time people need to get a therapy, they need to visit a hospital. This is because the medicine must be delivered slowly, the infusion would take several hours. During the drip, the blood pressure, pulse, and temperature will be measured on a frequent basis to monitor the body's reaction. If patients don't have any problems during the first hour of the infusion, the doctor or nurse who is caring for the person will increase the rate. After it's completed, the patient has to stay at the hospital for an hour to be monitored for any after-effects.
The rise in the prevalence of autoimmune illnesses such as multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome is driving the intravenous immunoglobulin market. This is due to technical improvements leading to the development of novel products and purification technologies. The rapid development in the number of neurological illnesses, as well as the geriatric population and patient pool, has spurred the demand for speedy and reliable treatment options. To diversify their revenue streams, all companies should enhance the R&D efforts in the development of unique products.
As people willingness to live longer and healthier lives, the demand for breakthrough medical technology solutions like intravenous immunoglobulin continues to rise. The population of the region is well aware of medical technologies and displays complete support for new technology in the region. This opens up chances for the medical technology industry, which is nearly completely made up of small and medium-sized businesses in Germany. One of the most fascinating areas of health care is making it easier for people to recuperate from surgical procedures.
International businesses in the sector are discovering that Germany, Europe's largest health market, is an excellent place to establish advanced technology like intravenous immunoglobulin’s presence and expand sales. The close partnership between research and industry has enabled Germany's medical technology industry to become a benchmark for quality, performance, and safety.
The Germany market dominated the Europe Intravenous Immunoglobulin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,028.3 million by 2028. The UK market is estimated to grow at a CAGR of 5.5% during (2022 - 2028). Additionally, The France market would witness a CAGR of 7.2% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty Pharmacy, and Others. Based on Application, the market is segmented into Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia & Myasthenia Gravis, Congenital AIDS & Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, Immune thrombocytopenia (ITP), and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Intravenous Immunoglobulin Market will Hit $17.3 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Grifols, S.A., Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG (Tiancheng International Investment Limited), LFB S.A., CSL Limited (CSL Behring), Octapharma AG, Kedrion S.p.A, and Bayer AG.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Specialty Pharmacy
- Others
By Application
- Immunodeficiency Diseases
- Chronic Inflammatory Demyelinating Polyneuropathy
- Hypogammaglobulinemia
- Chronic Lymphocytic Leukemia & Myasthenia Gravis
- Congenital AIDS & Multifocal Motor Neuropathy
- Kawasaki Disease
- Guillain-Barre Syndrome
- Immune thrombocytopenia (ITP)
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Grifols, S.A.
- Takeda Pharmaceutical Company Limited
- Baxter International, Inc.
- Biotest AG (Tiancheng International Investment Limited)
- LFB S.A.
- CSL Limited (CSL Behring)
- Octapharma AG
- Kedrion S.p.A
- Bayer AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intravenous Immunoglobulin Market, by Distribution Channel
1.4.2 Europe Intravenous Immunoglobulin Market, by Application
1.4.3 Europe Intravenous Immunoglobulin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Intravenous Immunoglobulin Market by Distribution Channel
3.1 Europe Hospital Pharmacy Market by Country
3.2 Europe Specialty Pharmacy Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Intravenous Immunoglobulin Market by Application
4.1 Europe Immunodeficiency Diseases Market by Country
4.2 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
4.3 Europe Hypogammaglobulinemia Market by Country
4.4 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
4.5 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country
4.6 Europe Kawasaki Disease Market by Country
4.7 Europe Guillain-Barre Syndrome Market by Country
4.8 Europe Immune thrombocytopenia (ITP) Market by Country
4.9 Europe Others Market by Country
Chapter 5. Europe Intravenous Immunoglobulin Market by Country
5.1 Germany Intravenous Immunoglobulin Market
5.1.1 Germany Intravenous Immunoglobulin Market by Distribution Channel
5.1.2 Germany Intravenous Immunoglobulin Market by Application
5.2 UK Intravenous Immunoglobulin Market
5.2.1 UK Intravenous Immunoglobulin Market by Distribution Channel
5.2.2 UK Intravenous Immunoglobulin Market by Application
5.3 France Intravenous Immunoglobulin Market
5.3.1 France Intravenous Immunoglobulin Market by Distribution Channel
5.3.2 France Intravenous Immunoglobulin Market by Application
5.4 Russia Intravenous Immunoglobulin Market
5.4.1 Russia Intravenous Immunoglobulin Market by Distribution Channel
5.4.2 Russia Intravenous Immunoglobulin Market by Application
5.5 Spain Intravenous Immunoglobulin Market
5.5.1 Spain Intravenous Immunoglobulin Market by Distribution Channel
5.5.2 Spain Intravenous Immunoglobulin Market by Application
5.6 Italy Intravenous Immunoglobulin Market
5.6.1 Italy Intravenous Immunoglobulin Market by Distribution Channel
5.6.2 Italy Intravenous Immunoglobulin Market by Application
5.7 Rest of Europe Intravenous Immunoglobulin Market
5.7.1 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel
5.7.2 Rest of Europe Intravenous Immunoglobulin Market by Application
Chapter 6. Company Profiles
6.1 Grifols, S.A
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.1.5.2 Acquisition and Mergers:
6.2 Takeda Pharmaceutical Company Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 Baxter International, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Biotest AG (Tiancheng International Investment Limited)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 LFB S.A.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 CSL Limited (CSL Behring)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Octapharma AG
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals and Trials:
6.8 Kedrion S.p.A
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 Bayer AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
TABLE 1 Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 2 Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 3 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 12 Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 13 Europe Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 33 Germany Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 34 Germany Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 35 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Germany Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 38 Germany Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 39 UK Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 40 UK Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 41 UK Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 UK Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 UK Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 44 UK Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 45 France Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 46 France Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 47 France Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 France Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 France Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 50 France Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 51 Russia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 52 Russia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 53 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 Russia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 56 Russia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 57 Spain Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 58 Spain Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 59 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Spain Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 62 Spain Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 63 Italy Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 64 Italy Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 65 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Italy Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 68 Italy Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 69 Rest of Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 70 Rest of Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 71 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Rest of Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 74 Rest of Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 75 Key information – Grifols, S.A.
TABLE 76 Key Information – Takeda Pharmaceutical Company Limited
TABLE 77 Key Information – Baxter International, Inc.
TABLE 78 key information – Biotest AG
TABLE 79 Key Information – LFB S.A
TABLE 80 key Information – CSL Limited
TABLE 81 Key Information – Octapharma AG
TABLE 82 key Information – Kedrion S.p.A
TABLE 83 Key Information – Bayer AG
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.